CENTRAL NERVOUS SYSTEM AND BRAIN CANCER: CLINICAL EXOME PANEL (Sec. & CNVs) – 41 genes
LabGenetics
Delivery time
3-4 weeks
Sample
Blood
The Central Nervous System and Brain Cancer Panel is designed to detect genetic variants associated with primary brain tumors and familial tumor predisposition syndromes. It includes genes related to gliomas (TP53, ATRX, IDH1/2), medulloblastomas (PTCH1, SUFU, SMARCB1), meningiomas (NF2, SMARCE1), ependymomas, and pituitary tumors (MEN1, AIP). It also covers genes associated with neurofibromatosis syndromes (NF1, NF2), tuberous sclerosis (TSC1, TSC2), and Li-Fraumeni syndrome (TP53). This test allows for precise molecular diagnosis, definition of familial risk, and guidance of therapeutic strategies. Genes analyzed: TP53, NF1, NF2, SMARCB1, SMARCE1, PTCH1, SUFU, TSC1, TSC2, PTEN, MEN1, AIP, and others. You can consult the complete list of genes analyzed by contacting Genotica.
Other tests
Preventive health test - AboutMe EXOME
545,00€
NEUROFIBROMATOSIS: GENES SMARCB1 Y LZTR1 (NGS-Sec) – ATG Medical
600,00€
Custom sequencing panels (1 to 15 genes)
660,00€